These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 6100646

  • 21. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.
    Sodroski J, Goh WC, Rosen C, Campbell K, Haseltine WA.
    Nature; ; 322(6078):470-4. PubMed ID: 3016552
    [Abstract] [Full Text] [Related]

  • 22. Lymphadenopathy associated virus and its etiological role in AIDS.
    Montagnier L, Chermann JC, Barré-Sinoussi F, Klatzmann D, Wain-Hobson S, Alizon M, Clavel F, Brun-Vezinet F, Vilmer E, Rouzioux C.
    Princess Takamatsu Symp; 1984; 15():319-31. PubMed ID: 6100650
    [Abstract] [Full Text] [Related]

  • 23. Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I.
    De Rossi A, Franchini G, Aldovini A, Del Mistro A, Chieco-Bianchi L, Gallo RC, Wong-Staal F.
    Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4297-301. PubMed ID: 2424024
    [Abstract] [Full Text] [Related]

  • 24. Expression of AIDS virus envelope gene in recombinant vaccinia viruses.
    Hu SL, Kosowski SG, Dalrymple JM.
    Nature; 1986 Jun; 320(6062):537-40. PubMed ID: 3008002
    [Abstract] [Full Text] [Related]

  • 25. Immunologic and virologic characterization of the primary infiltrating cells in the aqueous humor of human T-cell leukemia virus type-1 uveitis. Accumulation of the human T-cell leukemia virus type-1-infected cells and constitutive expression of viral and interleukin-6 messenger ribonucleic acids.
    Ono A, Mochizuki M, Yamaguchi K, Miyata N, Watanabe T.
    Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):676-89. PubMed ID: 9071222
    [Abstract] [Full Text] [Related]

  • 26. Reactivity of E. coli-derived trans-activating protein of human T lymphotropic virus type III with sera from patients with acquired immune deficiency syndrome.
    Barone AD, Silva JJ, Ho DD, Gallo RC, Wong-Staal FF, Chang NT.
    J Immunol; 1986 Jul 15; 137(2):669-73. PubMed ID: 3013999
    [Abstract] [Full Text] [Related]

  • 27. Structural and epidemiological features of primate lymphotropic retroviruses.
    Hunsmann G, Schneider J, Bayer H, Jurkiewicz E, Yamamoto N.
    Princess Takamatsu Symp; 1984 Jul 15; 15():109-18. PubMed ID: 6100632
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of replication of the etiologic agent of acquired immune deficiency syndrome (human T-lymphotropic retrovirus/lymphadenopathy-associated virus) by avarol and avarone.
    Sarin PS, Sun D, Thornton A, Müller WE.
    J Natl Cancer Inst; 1987 Apr 15; 78(4):663-6. PubMed ID: 2435942
    [Abstract] [Full Text] [Related]

  • 29. Implications of the discovery of HTLV-III for the treatment of AIDS.
    Yarchoan R, Mitsuya H, Matsushita S, Broder S.
    Cancer Res; 1985 Sep 15; 45(9 Suppl):4685s-4688s. PubMed ID: 2410113
    [Abstract] [Full Text] [Related]

  • 30. Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa.
    Calattini S, Chevalier SA, Duprez R, Bassot S, Froment A, Mahieux R, Gessain A.
    Retrovirology; 2005 May 09; 2():30. PubMed ID: 15882466
    [Abstract] [Full Text] [Related]

  • 31. Kaplan memorial lecture. The family of human lymphotropic retroviruses called HTLV: HTLV-I in adult T-cell leukemia (ATL), HTLV-II in hairy cell leukemias, and HTLV-III in AIDS.
    Gallo RC.
    Princess Takamatsu Symp; 1984 May 09; 15():13-38. PubMed ID: 6100633
    [Abstract] [Full Text] [Related]

  • 32. Narrow host range of AIDS-related retroviruses (YU-1, 2, 3, 4) isolated from Japanese hemophiliacs: inability to infect H9, Molt-4, and MT-4 cells.
    Yoshiyama H, Harada S, Kajii T, Yamamoto N.
    Jpn J Cancer Res; 1986 Jun 09; 77(6):514-6. PubMed ID: 3015850
    [Abstract] [Full Text] [Related]

  • 33. No genetic evidence for involvement of Deltaretroviruses in adult patients with precursor and mature T-cell neoplasms.
    Burmeister T, Schwartz S, Hummel M, Hoelzer D, Thiel E.
    Retrovirology; 2007 Feb 07; 4():11. PubMed ID: 17284327
    [Abstract] [Full Text] [Related]

  • 34. Advances in the isolation of HTLV-III from patients with AIDS and AIDS-related complex and from donors at risk.
    Markham PD, Salahuddin SZ, Popovic M, Patel A, Veren K, Fladager A, Orndorff S, Gallo RC.
    Cancer Res; 1985 Sep 07; 45(9 Suppl):4588s-4591s. PubMed ID: 2990690
    [Abstract] [Full Text] [Related]

  • 35. Nucleotide sequence analysis of a provirus derived from HTLV-1-associated myelopathy (HAM).
    Tsujimoto A, Teruuchi T, Imamura J, Shimotohno K, Miyoshi I, Miwa M.
    Mol Biol Med; 1988 Feb 07; 5(1):29-42. PubMed ID: 2897612
    [Abstract] [Full Text] [Related]

  • 36. Polymorphism of the 3' open reading frame of the virus associated with the acquired immune deficiency syndrome, human T-lymphotropic virus type III.
    Ratner L, Starcich B, Josephs SF, Hahn BH, Reddy EP, Livak KJ, Petteway SR, Pearson ML, Haseltine WA, Arya SK.
    Nucleic Acids Res; 1985 Nov 25; 13(22):8219-29. PubMed ID: 2999715
    [Abstract] [Full Text] [Related]

  • 37. HTLV-III: the etiologic agent of AIDS.
    Sarngadharan MG, DeVico AL, Bruch L, Schüpbach J, Gallo RC.
    Princess Takamatsu Symp; 1984 Nov 25; 15():301-8. PubMed ID: 6100648
    [Abstract] [Full Text] [Related]

  • 38. Natural killer activity from normal peripheral blood lymphocytes against a human T lymphotropic retrovirus type III (HTLV-III)-infected cell line.
    Sirianni MC, De Sanctis G, Macchi B, Soddu S, Ensoli F, Aiuti F, Fontana L.
    Diagn Clin Immunol; 1988 Nov 25; 5(6):297-303. PubMed ID: 3219779
    [Abstract] [Full Text] [Related]

  • 39. Molecular cloning and characterization of the HTLV-III virus associated with AIDS.
    Hahn BH, Shaw GM, Arya SK, Popovic M, Gallo RC, Wong-Staal F.
    Nature; 1988 Nov 25; 312(5990):166-9. PubMed ID: 6095086
    [Abstract] [Full Text] [Related]

  • 40. Protection of T cells against infectivity and cytopathic effect of HTLV-III in vitro.
    Mitsuya H, Matsushita S, Yarchoan R, Broder S.
    Princess Takamatsu Symp; 1984 Nov 25; 15():277-88. PubMed ID: 6085846
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.